Saturday, November 22, 2025 | 05:14 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

IIT Guwahati collaborates with Hester Biosciences for Covid-19 vaccine

The institute expects the coronavirus vaccine to be ready for animal studies by the end of this year

IIT Guwahati | Photo: IIT Guwahati website
premium

The work is currently in its early stage of development. The institute’s role will be to produce the recombinant vaccine candidate. | Photo: IIT Guwahati website

Avishek Rakshit Kolkata
The Indian Institute of Technology (IIT), Guwahati, is collaborating with Ahmedabad-based animal healthcare company Hester Biosciences to develop a vaccine against Covid-19. It expects the vaccine to be ready for animal studies by the end of this year.

The vaccine is planned to be based on the recombinant avian paramyxovirus-based vector platform. The recombinant avian paramyxovirus-1 will be used to express the immunogenic protein of SARS-CoV-2, and that will be a vaccine candidate for further study.

The avian paramyxovirus-1 has been explored as a vaccine vector for various animals and human pathogens and used to express the immunogenic protein of